Two Sigma Advisers’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,500
Closed -$216K 1426
2025
Q4
$216K Buy
+11,500
New +$174K ﹤0.01% 2099
2025
Q1
Sell
-14,000
Closed -$247K 2522
2024
Q4
$247K Buy
14,000
+3,600
+35% +$68.3K ﹤0.01% 2057
2024
Q3
$238K Sell
10,400
-18,300
-64% -$413K ﹤0.01% 2005
2024
Q2
$659K Buy
28,700
+15,200
+113% +$469K ﹤0.01% 1772
2024
Q1
$535K Sell
13,500
-14,200
-51% -$562K ﹤0.01% 1845
2023
Q4
$1.1M Buy
+27,700
New +$1.16M ﹤0.01% 1607

Other funds holding NRC

Two Sigma Advisers's NRC Position: Q1 2026 in Review

Two Sigma Advisers sold out of NRC Health Common Stock (NRC) in Q1 2026, closing a stake of 11,500 shares — an estimated $216K sold.

Two Sigma Advisers first reported a position in NRC in Q4 2023 and held it in 6 quarters. The position peaked at $1.1M in Q4 2023. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • Two Sigma Advisers reported no remaining NRC Health Common Stock position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 11,500 NRC Health Common Stock shares in Q1 2026, an estimated $216K.
  • Two Sigma Advisers first reported a position in NRC Health Common Stock in Q4 2023 and held it in 6 quarters.
  • Two Sigma Advisers's NRC Health Common Stock position peaked at $1.1M in Q4 2023.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.